Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropeptide Y and platelet aggregation by adrenaline.

H A Dewar1, M A Zar, A Oxley

  • 1Department of Pharmacological Sciences, Medical School, University of Newcastle upon Tyne, U.K.

Life Sciences
|January 1, 1989
PubMed
Summary

Neuropeptide Y does not cause platelet aggregation but inhibits adrenaline-induced responses in a dose-dependent manner. This finding suggests a potential role for neuropeptide Y in regulating platelet activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Problems of Coronary Ambulances.

Journal of the Royal College of Physicians of London·2019
Same author

Treatment of typhoid fever with convalescent whole blood.

Journal of the Royal Army Medical Corps·2010
Same author

Relapsing fever with nephritis and subarachnoid haemorrhage.

Lancet (London, England)·2010
Same author

The hospital nurse.

Journal of the Royal Society of Medicine·2010
Same author

Hydrolysis of acyl-homogeneous and fish oil triacylglycerols using desalted midgut extract from atlantic salmon, Salmo salar.

Lipids·2008
Same author

The effect of palytoxin on neuromuscular junctions in the anococcygeus muscle of the rat.

Journal of neurocytology·1997

Area of Science:

  • Biochemistry
  • Hematology
  • Pharmacology

Background:

  • Platelet aggregation is a critical process in hemostasis and thrombosis.
  • Adrenaline is a known potent inducer of platelet aggregation.
  • Neuropeptide Y (NPY) is a peptide neurotransmitter with various physiological roles.

Purpose of the Study:

  • To investigate the direct effect of neuropeptide Y on human platelet aggregation.
  • To determine if neuropeptide Y modulates the aggregatory response induced by adrenaline.

Main Methods:

  • Human platelet-rich plasma was used for aggregation studies.
  • Platelet aggregation was measured in the presence and absence of neuropeptide Y.
  • The effect of neuropeptide Y on adrenaline-induced platelet aggregation was assessed.

Related Experiment Videos

Main Results:

  • Neuropeptide Y alone did not induce platelet aggregation at the tested concentrations.
  • Neuropeptide Y significantly slowed and inhibited adrenaline-induced platelet aggregation.
  • This inhibitory effect was found to be dose-dependent.

Conclusions:

  • Neuropeptide Y exhibits anti-aggregatory properties in human platelets.
  • NPY may play a role in modulating platelet responsiveness to adrenergic stimuli.
  • Further research is warranted to explore the clinical implications of NPY in platelet function and cardiovascular health.